Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,09 USD | +7,92% | -5,22% | +98,18% |
Attività
Numero di dipendenti: 73
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
René Russo
CEO | Chief Executive Officer | 49 | 22/05/19 |
Kevin Brennan
DFI | Director of Finance/CFO | 54 | - |
Chief Tech/Sci/R&D Officer | - | 01/10/22 | |
Chief Operating Officer | 42 | 01/03/21 | |
Uli Bialucha
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/21 |
Scott Coleman
PRN | Corporate Officer/Principal | - | 01/06/22 |
Stacey J. Davis
PRN | Corporate Officer/Principal | - | 17/05/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Paul Clancy
CHM | Chairman | 62 | 23/07/20 |
Daniel Curran
BRD | Director/Board Member | 57 | 01/12/20 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 15/09/22 |
Sara Bonstein
BRD | Director/Board Member | 43 | 17/08/21 |
Robert Ross
BRD | Director/Board Member | 50 | 16/06/22 |
René Russo
CEO | Chief Executive Officer | 49 | 22/05/19 |
Christina Rossi
BRD | Director/Board Member | 48 | 01/04/21 |
Yuan Xu
BRD | Director/Board Member | 56 | 04/01/22 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 34 479 103 | 23 477 593 ( 68,09 %) | 5 617 ( 0,0163 %) | 68,09 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+98,18% | 37,57 Mln | |
+1,51% | 42,75 Mrd | |
+8,57% | 41,34 Mrd | |
+49,22% | 41,61 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione XLO
- Società Xilio Therapeutics, Inc.